AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (July 18, 2007). doi:10.1152/ajprenal.00209.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/3/F680    most recent
00209.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Y.
Right arrow Articles by Varghese, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y.
Right arrow Articles by Varghese, Z.
Submitted on May 4, 2007
Accepted on July 11, 2007

Inflammatory cytokines disrupt LDL receptor feedback regulation and cause statin resistance: a comparative study in human hepatic cells and mesangial cells

Yaxi Chen1, Xiong Z Ruan2*, Qiu Li1, Ailong Huang1, John F Moorhead3, Stephen H Powis3, and Zac Varghese3

1 Centre for Lipid Research, Key Laboratory of Molecular Biology on Infectious Disease, Chongqing Medical University, Chongqing, Chongqing, China
2 Centre for Nephrology, Royal Free and University College Medical School, London, United Kingdom; Centre for Lipid Research, Key Laboratory of Molecular Biology on Infectious Disease, Chongqing Medical University, Chongqing, Chongqing, China
3 Centre for Nephrology, Royal Free and University College Medical School, London, United Kingdom

* To whom correspondence should be addressed. E-mail: x.ruan{at}medsch.ucl.ac.uk.

LDL receptor (LDLr) is widely expressed in both liver and peripheral tissue. We aimed to clarify tissue specific regulation in hepatic cell line (HepG2) cells and human kidney mesangial cells (HMCs) under physiological and inflammatory conditions. We have demonstrated that the concentration of LDL for 50% inhibition of LDLr mRNA expression (IC50) in HepG2 was 75µg/ml, but only 30µg/ml in HMCs. The concentration of mevastatin, an HMGCoA reductase inhibitor, which achieved 200% up-regulation of LDLr (UC200) in HepG2 cells was 0.7µM, which is much lower than 2.8µM in HMCs. Inflammatory stress increased IC50 to 80µg/ml and 75µg/ml, UC200 to 2.8µM, and 4.2µM in HepG2 and HMCs, respectively. There was obvious SCAP accumulation in the Golgi in HepG2 cells but not in HMCs in the presence of high concentration of LDL. IL-1{beta} further increased SCAP accumulation in HepG2 and HMCs in the presence of high concentration of LDL. These results indicate that LDLr in HepG2 cells has a relative resistant phenotype for down-regulation while LDLr in HMCs is very sensitive for down-regulation. Inflammatory cytokine disrupts LDLr negative feedback regulation induced by intracellular cholesterol in both cell types, to a greater degree in HMCs, which could be one reason why HMCs are more prone to become foam cells under inflammatory stress. Inflammation also causes statin resistance; therefore a high concentration of statin may be required to achieve the same biological effect.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.